Evidence map›Paper›PMID 38816613›Full record

ArticleNature2024

Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T

Xiangnan Guan, Ruozhen Hu, Yoonha Choi, Shyam Srivats, Barzin Y Nabet, John Silva, Lisa McGinnis, Robert Hendricks, Katherine Nutsch, Karl L Banta and 21 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Xiangnan GuanGenentech Inc., South San Francisco, CA, USA.
Ruozhen HuGenentech Inc., South San Francisco, CA, USA.
Yoonha ChoiGenentech Inc., South San Francisco, CA, USA.
Shyam SrivatsGenentech Inc., South San Francisco, CA, USA.
Barzin Y NabetGenentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-4824-3533
John SilvaGenentech Inc., South San Francisco, CA, USA.
Lisa McGinnisGenentech Inc., South San Francisco, CA, USA.
Robert HendricksGenentech Inc., South San Francisco, CA, USA.
Katherine NutschGenentech Inc., South San Francisco, CA, USA.
Karl L BantaGenentech Inc., South San Francisco, CA, USA.
Ellen DuongGenentech Inc., South San Francisco, CA, USA.
Alexis DunkleGenentech Inc., South San Francisco, CA, USA.
Patrick S ChangGenentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5737-1011
Chia-Jung HanGenentech Inc., South San Francisco, CA, USA.
Stephanie MittmanGenentech Inc., South San Francisco, CA, USA.
Nandini MoldenGenentech Inc., South San Francisco, CA, USA.
Pallavi DaggumatiGenentech Inc., South San Francisco, CA, USA.
Wendy ConnollyGenentech Inc., South San Francisco, CA, USA.
Melissa JohnsonSarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-9874-1314
Delvys Rodriguez AbreuHospital Universitario Insular de Gran Canaria, Las Palmas, Spain.ORCID http://orcid.org/0000-0003-0506-1366
Byoung Chul ChoYonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea.ORCID http://orcid.org/0000-0002-5562-270X
Antoine ItalianoInstitut Bergonie CLCC Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0002-8540-5351
Ignacio Gil-BazoClínica Universidad de Navarra, CIMA Universidad de Navarra Pamplona, Pamplona, Spain.ORCID http://orcid.org/0000-0002-2626-5109
Enriqueta FelipVall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Ira MellmanGenentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-6132-7299
Sanjeev MariathasanGenentech Inc., South San Francisco, CA, USA.
David S ShamesGenentech Inc., South San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-5900-1177
Raymond MengGenentech Inc., South San Francisco, CA, USA.
Eugene Y ChiangGenentech Inc., South San Francisco, CA, USA.
Robert J JohnstonGenentech Inc., South San Francisco, CA, USA. johnston.robert@gene.com.ORCID http://orcid.org/0009-0008-4774-8514
Namrata S PatilGenentech Inc., South San Francisco, CA, USA. patil.namrata@gene.com.ORCID http://orcid.org/0000-0001-6156-684X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38816613
PMCPMC11168920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.